Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients

计划入组 119 人 · 首次发布于 2025 年 4 月 29 日

Safety and Efficacy Study BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic or Pseudophakic Presbyopia

计划入组 182 人 · 首次发布于 2022 年 3 月 8 日

Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

计划入组 629 人 · 首次发布于 2021 年 11 月 26 日

PF-05221304 + PF-06865571

PF-610355/PF-258210

PF-562271

PF PRISM C.V.

Netherlands

PF Consumer Healthcare Canada ULC

Canada

PF Consumer Healthcare B.V. (Puerto Rico Operations) LLC

United States

Tenpoint Therapeutics Submits First International NDA for BRIMOCHOL PF Presbyopia Treatment in South Korea

Visus Therapeutics' Brimochol PF Meets Endpoints in Phase 3 Presbyopia Trial

Tenpoint Therapeutics' BRIMOCHOL™ PF Shows Positive Phase 3 Results for Presbyopia